Tagged with IP

biotech The founder of this spin-off of the Autonomous University of the State of Morelos focusing on biologicals for human and veterinary use offers an overview of how the company came into life, the lack of culture at Mexican universities of filing patents for academic research and the potential of the…

clinical trials Klinsel’s CEO discusses the company’s ambitions of growth in a very competitive CRO market and stresses that local experience is truly a distinguishing factor and this is why they are already partnering and performing trials for one of the country’s largest local manufacturers.     Klinsel was appointed last year…

Cell2B David Malta and Daniela Couto, Co-founders of Cell2B, discuss the company’s origins and plans to achieve market authorization, and what makes the fledgling company the partner of choice.   What do you see as Portugal’s capacity for the local life sciences industry to grow? DM: Portugal is one of the best-positioned…

Generics Kenneth Y Hartigan-Go, Acting Director General of the Food and Drug Administration Philippines (FDA) discusses the current state of regulations processes, strategies that the FDA are applying to the major challenges being presented, and further elaborates on the affect that the universal healthcare would have on the Filipino market.  One…

Philippines The three graphs below give a look into the performance of the Philippines healthcare industry, based upon a few key indicators: healthcare expenditure, a breakdown of total healthcare spending in recent years, and the evolution of the number of hospital beds per 1,000 patients. The first chart shows the breakdown…

Array Jeffrey Williams, Assistant Vice President of Cognizant Philippines, talks about the high rate of Filipino nurses being outsourced to the US and other countries, the recent acquisition of the Medicall by Cognizant, and what the future growth plans look like for the company’s next five years.   Mr. Williams, you…

Generics Earl Stanley Perez, General Manager of Meyerf Philippines, explains the importance of focusing on a few niches to succeed in a growing in a competitive market such as the Philippines, stressing the need for local companies to raise brand awareness and not only target the private sector but partner with…

Generics Al Z. Castro, General Manager of IMS Health Philippines, speaks about the ongoing challenges of bringing about awareness and acceptance of generics medicine to the local population, how this will affect IMS Health, and what their strategy is going forward over the next five years. IMS Health has previously classified…

Generics Ibrahim Monchito, Deputy Executive Director of the Department of Science and Technology ICT Office stresses the need to bring higher value to the HIM industry as a means to protect the local industry and help companies grow. He further elaborates on a government point of view of the actions taken…

MNCs Pedro Miranda Jr., General Manager of Pacific Healthcare Philippines, talks about the decision to join Pacific Healthcare in the Philippines, how the company’s diversification strategy has evolved over the past two years, and what’s in store for the company in terms of new principals and partnerships in the next five…

Medical Devices J. De Ruyter ‘Toto’ C Oroceo, President & General Manager of Delex Pharma International, talks about the company’s efforts at making pharmaceutical products in the Philippines more affordable to all levels of society, not just the upper class, and further discusses the motivation for the switch from medical devices to…

Medical Devices J. De Ruyter ‘Toto’ C Oroceo, President & General Manager of Delex Pharma International, talks about the company’s efforts at making pharmaceutical products in the Philippines more affordable to all levels of society, not just the upper class, and further discusses the motivation for the switch from medical devices to…